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PARP1 is the main sensor of single- and double-
strand breaks in DNA and, in building chains of
poly(ADP-ribose), promotes the recruitment of
many downstream signaling and effector proteins
involved in the DNA damage response (DDR). We
show a robust physical interaction between PARP1
and the replication fork protein TIMELESS, distinct
from the known TIMELESS-TIPIN complex, which
activates the intra-S phase checkpoint. TIMELESS
recruitment to laser-induced sites of DNA damage
is dependent on its binding to PARP1, but not
PARP1 activity. We also find that the PARP1-
TIMELESS complex contains a number of estab-
lished PARP1 substrates, and TIMELESS mutants
unable to bind PARP1 are impaired in their ability to
bind PARP1 substrates. Further, PARP1 binding to
certain substrates and their recruitment to DNA dam-
age lesions is impaired by TIMELESS knockdown,
and TIMELESS silencing significantly impairs DNA
double-strand break repair. We hypothesize that
TIMELESS cooperates in the PARP1-mediated DDR.
INTRODUCTION
TIMELESS (tim1) is a protein originally characterized in
Drosophila melanogaster as a core component of the circadian
clock that regulates daily rhythms. Orthologs in many species,
including mammals, have been identified, but mammalian
TIMELESS shares greater similarity to a Drosophila paralog of
tim1, called timeout or tim2 (Gotter, 2006). While tim2 retains a
residual role for light entrainment, suggesting an evolutionary
link to tim1, it is mainly an essential gene required for DNA repli-
cation and chromosome stability (Benna et al., 2010). Accord-Cingly, although mammalian TIMELESS has a circadian function
in the superchiasmatic nucleus of the mouse (Barnes et al.,
2003; McFarlane et al., 2010), it is best characterized for its
role in regulating the response to DNA replication stress (Leman
and Noguchi, 2012; McFarlane et al., 2010). At least partially
because of this fundamental function, knockout of murine
TIMELESS confers early embryonic lethality, usually during the
pre- or peri-implantation period (embryonic day 5.5 [E5.5] to
E7.5) (Gotter et al., 2000).
In response to the stalling of DNA replication forks, single-
stranded DNA (ssDNA) regions are generated and rapidly coated
by the replication protein A (RPA) complex. TIPIN (TIMELESS in-
teracting protein) recognizes and binds RPA-coated DNA in a
conserved complex with TIMELESS (Gotter, 2003). Subsequent
interaction with CLASPIN promotes ATR-mediated phosphory-
lation and activation of CHK1, resulting in the inhibition of
CDK1 and, with it, mitotic events (Ciccia and Elledge, 2010). In
C. elegans and mammals, the TIMELESS-TIPIN complex has
been demonstrated to interact with members of the cohesin
complex, and these studies have suggested a role in establishing
and maintaining sister chromatid cohesion during and after DNA
replication (Leman and Noguchi, 2012). Significantly, until now,
TIPIN has been the major known binding partner of TIMELESS
in both mammals and yeast.
In a genome-wide small interfering RNA (siRNA) screen,
TIMELESS was identified as a gene involved in maintaining
genome stability, as measured by spontaneous formation of
g-H2AX foci when its expression is silenced (Paulsen et al.,
2009). Other effects of TIMELESS depletion include greater
genomic instability (more frequent breaks and abnormal chromo-
somes uponmetaphase spread), enhanced formation of double-
strand breaks (DSBs) in S phase cells, and increased RAD51 and
RAD52 foci (Leman and Noguchi, 2012). Moreover, after
TIMELESS knockdown in serum-released fibroblasts, sister
chromatid exchange (SCE) substantially increased, suggesting
that TIMELESS may have a role in preventing recombination
events during unperturbedDNA replication (Urtishak et al., 2009).ell Reports 13, 451–459, October 20, 2015 ª2015 The Authors 451
In summary, TIMELESS has an established role in the intra-S
phase checkpoint, which requires its association with TIPIN.
However, TIMELESS appears to play additional less character-
ized functions, including in circadian clock regulation. Because
of our interest in both the response to genotoxic stress (Basser-
mann et al., 2008; Busino et al., 2003; D’Angiolella et al., 2012;
Peschiaroli et al., 2006; Skaar et al., 2009) and circadian clock
regulation (Busino et al., 2007; Xing et al., 2013), we decided to
investigate further the cellular functions of TIMELESS and found
that TIMELESS robustly binds PARP1 (also called ADP-ribosyl-
transferase 1 or ARTD1).
PARP family proteins polymerize poly(ADP-ribose) (PAR)
onto acceptor proteins using the metabolite NAD+ as a sub-
strate; indeed, they are the primary consumers of cellular
NAD+ (Barkauskaite et al., 2015; Thomas and Tulin, 2013).
PARylation, the process of adding branched PAR chains to
proteins, has been implicated in numerous cellular and devel-
opmental functions, from chromatin remodeling and transcrip-
tional control to DNA damage recognition and repair to stem
cell differentiation, apoptosis, and glycolysis (Bai, 2015).
PARylation of proteins occurs mainly on Lys, Glu, or Asp resi-
dues and can be formed by branched or elongated chains.
The human PARP protein family is composed of 17 PARPs, of
which 3 (PARP1, PARP2, and PARP3) are known to possess
DNA binding activity. PARP1 is the main sensor of single-strand
breaks (SSBs) and DSBs in DNA, and its localization is
restricted to the nucleus, unless cleaved just prior to apoptosis
when DNA repair becomes futile and the cellular pool of NAD+
and ATP should be preserved.
PARylated chains can grow to over 200 U of ADP-ribose,
serving as a large, negatively charged platform for other
proteins. In the presence of nicks and breaks, PARP1 poly-
merizes extensive amounts of PAR chains onto histone and
other proteins, including itself, and is, in essence, its own
best target. PARylation of histones proximal to DNA damage
results in an alteration in the net charge of histones and the
unwinding of the nucleosome-DNA complex, providing access
to DNA lesions for repair. Auto- and substrate-PARylation by
PARP1 establishes and amplifies the DNA damage signal,
providing a cellular flare for recruitment of necessary repair
factors and activation of effector proteins involved in the
DNA damage response (DDR), including the master regulators
of the DDR: ATM, ATR, and DNA-PK (Ciccia and Elledge,
2010).
There appears to be some ability for PARP2 to compensate for
the absence of PARP1, since PARP1/mice are viable whereas
PARP1/;PARP2/ double-knockout mice are embryonic le-
thal (Bai, 2015). PARP1 knockout mice, however, do display a
number of phenotypes consistent with the known functions of
PARP1. Lack of PARP1 activity leads to slow cell-cycle progres-
sion and sensitization to genotoxic stress. PARP1/ cells
exhibit radiosensitivity and genomic instability when challenged
with genotoxic agents. Further, PARP1 knockout and knock-
down and chemical inhibition of PARP1 increase the formation
of g-H2AX and RAD51 foci, suggesting a dependence on homol-
ogous recombination (HR) repair in cells lacking functional
PARP1. In fact, a small-molecule PARP1 inhibitor has been
recently approved for clinical use in breast cancer patients452 Cell Reports 13, 451–459, October 20, 2015 ª2015 The Authorswith gene mutations conferring a loss of HR (e.g., BRCA1,
BRCA2) (Feng et al., 2015).
While traditionally associated with two different pathways of
maintaining genome integrity, we identified a robust, physical
interaction between TIMELESS and PARP1. In the studies pre-
sented herein, we investigated the functional importance of
this interaction and suggest that TIMELESS contributes to the
DDR functions of PARP1.
RESULTS
TIMELESS Forms a Stable Complex with PARP1
Wenoticed thatwhenwe immunoprecipitated taggedTIMELESS
after its expression in human cells, by staining with either Pon-
ceauSor silver stainingdyes,weconsistently detected asecond,
faster migrating band that co-precipitated at an apparent, near-
stoichiometric ratio with TIMELESS (Figures 1A and S1A). Insert-
ing a FLAG-tag on either the N terminus or the C terminus of
TIMELESS co-precipitated the identical band, suggesting that
the band is not a cleavage or degradation product of the bait pro-
tein. To uncover the identity of this putative binding partner, we
coupled affinity purification with mass spectrometry. STREP-
FLAG-tagged TIMELESS or an empty vector construct were
transfected into HEK293T cells. Protein complexes were purified
and subjected to SDS-PAGE (Figure S1A). The co-precipitating
band was then excised, subjected to mass spectrometry anal-
ysis, and identified as PARP1, a protein of the molecular weight
corresponding to our observed band.
To confirm TIMELESS-PARP1 interaction and evaluate its
specificity, we immunoprecipitated a panel of N-terminally
FLAG-tagged circadian clock proteins with an anti-FLAG resin.
We found that TIMELESS was the only protein able to bind
endogenous PARP1, despite the fact that the levels of immuno-
precipitated TIMELESS were much lower than that of any other
immunoprecipitated protein (Figure 1B).We confirmed the recip-
rocal interaction by immunoprecipitating FLAG-tagged PARP1
and demonstrating its binding to endogenous TIMELESS
(Figure 1C). In contrast, FLAG-tagged NAMPT (the enzyme
providing NAD+ to PARPs), FLAG-tagged PARG (the major de-
PARylating enzyme), and FLAG-tagged IDUNA (an ubiquitin
ligase that binds PARylated substrates) did not co-precipitate
TIMELESS (Figures 1C and S1B). Notably, interaction between
endogenous PARP1 and endogenous TIMELESS was also
observed (Figure 1D).
Size exclusion chromatography showed that much of the
endogenous pool of PARP1 resides in rather low-molecular-
weight complexes in whole-cell extracts (peaking in fraction
15), estimated to reflect monomeric PARP1 (Figure S1C). How-
ever, the subpopulation of endogenous PARP1 bound to
FLAG-tagged TIMELESS shifted to much higher molecular
weights, peaking in fractions 6–8, suggesting that TIMELESS
and PARP1 form a complex containing other proteins.
The interaction between TIMELESS and PARP1 appeared to
be direct and not mediated by DNA, since it was stable in the
presence of nucleases (TurboNuclease or Benzonase) and after
sonication. Accordingly, when we employed super-resolution
microscopy, we found that in U2OS cells TIMELESS and
PARP1 foci showed a close association and often overlapped
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Figure 1. TIMELESS Physically Interacts with PARP1
(A) HEK293T cells were transfected with the indicated FLAG-tagged proteins. 24 hr post-transfection, cells were harvested and lysed. Cell extracts were
subjected to immunoprecipitation with a-FLAG resin and stained with Ponceau S. MWM, molecular weight markers.
(B) The experiment was performed as in (A), except that whole-cell extracts (WCEs) were subjected to immunoprecipitation (IP) with a-FLAG resin and
immunoblotted as indicated. EV, empty vector. Asterisks denote FLAG-tagged proteins.
(C) The experiment was performed as in (B).
(D) Lysates of U2OS cells were immunoprecipitated with either an antibody against TIMELESS or a rabbit IgG and immunoblotted as indicated.
(E) Super-resolution images of TIMELESS and PARP1 in U2OS cells selected from regions of the nucleus shown in Figure S1D. Scale bar, 400 nm.
(F) Super-resolution images of TUNEL, TIMELESS, and PARP1 in neocarzinostatin treated U2OS cells showing that TIMELESS and PARP1 are found at DNA
damage sites.(Figures 1E, 1F, and S1D), supporting the hypothesis of a direct
physical binding.
Mapping of the PARP1 Binding Motif in TIMELESS
Next, we systematically mapped the binding site in TIMELESS
that is responsible for its interaction with PARP1. Using the
COILS software, we performed a coiled-coil structure prediction
analysis of the protein in order to avoid disruption of highly or-
dered regions of the protein when generating truncation mutants
(Figure S2A). Based on this analysis, we created N-terminally
FLAG-tagged truncated TIMELESS mutants, whose N terminus
also contains a canonical SV40 nuclear localization signal, in or-
der to avoid mischaracterization of the binding capacity of a
mutant that cannot properly localize to the nucleus. The first
set of truncation mutants indicated the importance of the far
C terminus of TIMELESS, between residues 1,089 and 1,100 of
the 1,208-amino-acid protein, for PARP binding (Figures 2A
and S1C). This result was confirmed and extended by generatingC5-amino-acid deletion mutants within the 1,070–1,109 region
(summarized in Figure 2B). Next, we undertook triple Ala scan-
ning mutagenesis of this region as well as mutation (both to Ala
and Asp) of the phosphorylable residues present in this region
and its surroundings (Figures 2A–2C). Briefly, the results of the
Ala scanning mutagenesis showed that residues 1,089–1,092
(TQLR) and 1,097–1,099 (SLS) are crucial for the interaction be-
tween TIMELESS and PARP1. Interestingly, of 12 mutants of
phosphorylable residues only one, T1078D (a TIMELESS mutant
in which Thr1078 was mutated to a phosphomimicking Asp res-
idue), was entirely unable to bind PARP1 (Figure 2A). The results
of this extensive mutational analysis are summarized in Fig-
ure 2B, and they suggest that seven residues (1,089–1092 and
1,097–1,099) of TIMELESS are implicated in its interaction with
PARP1 and that phosphorylation of Thr1078 may inhibit this
binding. We compared this region of human TIMELESS to that
of other species and found that the region is largely conserved
in vertebrates (Figure S2B).ell Reports 13, 451–459, October 20, 2015 ª2015 The Authors 453
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Figure 2. Identification of the PARP1 Binding Site in TIMELESS
(A) HEK293T cells were transfected with either an empty vector (EV), FLAG-tagged TIMELESS, or FLAG-tagged TIMELESS mutants as indicated. Asterisks
indicate the insertion of a STOP codon after the numerically specified codon. 24 hr post-transfection, WCEs were subjected to IP with a-FLAG resin and im-
munoblotted as indicated.
(B) Schematic representation of TIMELESS mutants tested for binding to PARP1. TIMELESS mutants that interacted with endogenous PARP1 are designated
with the symbol (+); those unable to co-precipitate PARP1 are designated with the symbol ().
(C) The experiment was performed as in (A), except that different TIMELESS mutants were used.TIMELESS Is Recruited to DNA Damage Sites in a
PARP1-Dependent but PARP1-Activity-Independent
Manner
Having found that TIMELESS stably binds to PARP1, we hypoth-
esized that TIMELESS may have an unexplored role in DNA
repair, distinct from its previously characterized role in signaling
DNA replication stress. We thus generated cells stably express-
ing fluorescently tagged versions of both TIMELESS and PARP1
under the control of a weak retroviral promoter from which exog-
enous proteins are expressed at near-physiological levels (Fig-
ure S3A). Using these tools, we investigated the recruitment of
TIMELESS and PARP1 to laser-induced sites of DNA damage
(Mortusewicz et al., 2007). We observed that both proteins are
recruited to sites of DNA damage ‘‘spots’’ with identical kinetics
(Figure 3A), within seconds (the limit of detection) of the introduc-
tion of DNA damage.
In subsequent experiments, we generated kinetic plots using
the intensity data derived from the live-cell images. In order to
evaluate recruitment per se, and to subtract the contribution of
protein diffusion, i.e., a fluorescence recovery after photobleach-
ing (FRAP) effect, we developed an analysis method to compare454 Cell Reports 13, 451–459, October 20, 2015 ª2015 The Authorsthe damage spot to the nearby bleached area. A region ‘‘A’’ at
the center of the lesion was compared to a region ‘‘B’’ in the
area immediately adjacent, where bleaching also occurred. We
subtracted the background intensity from a distant, dark ‘‘C’’ re-
gion of the slide from both A and B, such that we defined a rela-
tive fluorescence unit (RFU) as (A  C)/(B C) (Figure S3B). This
value was calculated for each frame of each image, and we set a
stringency that the starting image should have a value with no
greater than 10% deviation (0.9 < (A  C)/(B  C) > 1.1). We
then averaged these values over the course of many live-cell im-
aging time courses for a given sample (n ranging between 15 to
50 per experimental group) and computed the SE for each time
point. Using this method, we characterized the dependence of
TIMELESS on PARP1 for recruitment to these sites of damage.
GFP-TIMELESS peaked at DNA damage sites at 8 s after irra-
diation, after which the signal decreased steadily (Figures 3B–
3D). Approximately 50% of GFP-TIMELESS dissociated after
45 s, and complete dissociation occurred within 2 min (not
shown). When PARP1 protein levels were reduced via siRNA (us-
ing two different oligos, individually), TIMELESS recruitment was
greatly reduced and nearly abolished (Figures 3B, 3C, and S3E).
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Figure 3. TIMELESS Requires PARP1, but Not Its Activity, to Be Recruited to DNA Damage Sites
(A) TIMELESS-Tomato and PARP1-GFP were stably co-transfected in U2OS cells and their recruitment to sites of DNA damagewas captured by live cell imaging
following laser microirradiation. Times are indicated in seconds.
(B) U2OS cells stabling expressing GFP-TIMELESS were depleted of PARP1 for three days using siRNA oligo #1, and the kinetics of TIMELESS recruitment to
DNA damage sites were assessed by live cell imaging of laser-induced lesions. For each condition, nR 28. SE is shown for each time point. Panels below show
efficiency of knockdowns using western blot.
(C) U2OS cells stabling expressing GFP-TIMELESS were treated for 1 hr with inhibitors to PARP1, ATM, DNA-PK, and CDK1 prior to laser microirradiation. Next,
kinetics of TIMELESS recruitment to DNA damage sites were assessed by live-cell imaging of laser-induced lesions. PARP1 knockdown (using oligo #2) was used
for comparison. For each condition, nR 20. SE is shown for each time point.
(D) U2OS cells stabling expressing either wild-type GFP-TIMELESS or two GFP-TIMELESS mutants that do not bind PARP1 were subjected to laser micro-
irradiation. Next, kinetics of recruitment of wild-type TIMELESS and TIMELESSmutants to DNAdamage siteswere assessed by live-cell imaging of laser-induced
lesions. For each condition, nR 15. SE is shown for each time point.However, when cells were challenged with the PARP1 enzymatic
inhibitor PJ34, TIMELESS recruitment was not reduced and,
interestingly, was significantly enhanced (Figures 3C, S3C, and
S3E). This distinction is important, because PARP1 enzymatic in-
hibition completely abolishes the recruitment of PARP1 sub-
strates and many early DNA damage effectors to sites of DNA
damage (Izhar et al., 2015; Mortusewicz et al., 2007). We
concluded that it is the physical interaction with PARP1 protein,
and not PARP1 enzymatic function, that influences the recruit-
ment of TIMELESS to sites of DNA damage.
We further validated this hypothesis by evaluating the ability of
TIMELESS mutants that do not bind PARP1 to be recruited to
sites of laser-induced DNAdamage.We investigated the kinetics
of recruitment of these TIMELESS mutants and found that the
T1078D point mutation, consistently and with little variation,Ccompletely abolished the recruitment of TIMELESS to DNA dam-
age sites (Figures 3D, S3D and S3E), in agreement with its ability
to inhibit PARP1 binding. Similarly, the SLS/AAA mutant was
also robustly and significantly impaired in its ability to move to
DNA damage sites. However, the TQL/AAA mutant, which by
immunoprecipitation does not appear to bind PARP1 (Figure 2C),
showed a more modest impairment (although still significant),
owing to a loosely bimodal distribution of data (Figure S3D),
which could be explained by a residual binding between the
two proteins in intact cells. We therefore concluded that
TIMELESS recruitment to sites of DNA damage is dependent
upon its ability to interact with PARP1.
We further characterized the recruitment of TIMELESS to
laser-induced sites of damage using candidate inhibitors for pro-
teins whose enzymatic activity often allows the recruitment ofell Reports 13, 451–459, October 20, 2015 ª2015 The Authors 455
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Figure 4. TIMELESS Stabilizes PARP1 Interaction with Its Substrates upon DNA Damage
(A) HEK293T cells were transfected with either an EV or the indicated FLAG-tagged proteins. 24 hr post-transfection, WCEs were subjected to IP with a-FLAG
resin and immunoblotted as indicated. Ex. Prot., exogenous proteins.
(B) The experiment was performed as in (A). Gels in the bottom panels were loaded as indicated in the upper panels, except that MWMs were omitted. Asterisks
denote nonspecific bands.
(legend continued on next page)
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DNA repair factors at damage sites. We inhibited ATM
(KU60019), ATR (AZ20), DNA-PK (NU7441), and CDK1
(RO3306) and found that none of these impaired TIMELESS
recruitment in response to laser ablation (Figures 3C and S3C).
The TIMELESS-PARP1 Complex Binds Many PARP1
Substrates Involved in the DNA Damage Response
The fraction of PARP1 that immunoprecipitates with TIMELESS
resides in high-molecular-weight protein complexes (Fig-
ure S1B). In order to understand the context of the interaction
between TIMELESS and PARP1 and the other proteins involved
in these larger complexes, we again employed a proteomic
approach. We expressed both FLAG-tagged TIMELESS and
hemagglutinin (HA)-tagged PARP1 in HEK293T cells and then
performed a sequential immunopurification of the two proteins.
First, we pulled down TIMELESS using an anti-FLAG antibody
and eluted by competition with an excess of FLAG peptide.
10% of the eluate of the first immunoprecipitation was set aside,
and the remaining 90% was subjected to a second immunopre-
cipitation using HA resin and elution using 1% SDS. The two
eluates were evaluated by silver staining (Figure S4A) and
mass spectrometry analysis (Figure S4B). We uncovered that
many proteins previously described as definitive or putative
PARP1 substrates (i.e., mostly proteins involved in the early
phases of the DDR) were present in both the first and second
eluate, suggesting that they are present in the same complex
with TIMELESS and PARP1. In contrast, TIPIN, whose binding
to TIMELESS is relevant in the context of the response to DNA
replication stress, was found to elute with TIMELESS in the first
immunoprecipitation, but not in the TIMELESS-PARP1 complex
analyzed after the second immunoprecipitation. Similarly, DNA-
PK, KU70, and KU80 were eluted only in the first immunoprecip-
itation. Therefore, we cannot exclude that TIMELESS and
PARP1 bind DNA-PK, KU70, and KU80 independently of each
other.
We next confirmed the binding of these interactors by immu-
noprecipitation followed by western blotting. We were able to
not only confirm the binding of PARP1 to known interactors,
but also demonstrate their interaction with TIMELESS (Fig-
ure 4A). We also confirmed that TIPIN only bound TIMELESS,
but not PARP1. Interestingly, DNA-PK was found to stably co-
precipitate only with TIMELESS, but its binding to PARP1 was
observed as only slightly above background. The binding data(C) U2OS cells were transfected overnight with either an siRNA to TIMELESS or a c
either an EV or FLAG-tagged PARP1. 24 hr post-transfection, WCEs were subje
denote non-specific band. The experiment was repeated three times with identic
(D) PARP1 recruitment is impaired after laser microirradiation following knockdow
TIMELESS for three days using siRNA, and the kinetics of PARP1recruitment to D
For each condition, nR 15. SE is shown for each time point.
(E) KU80 recruitment is impaired after laser microirradiation following knockdow
TIMELESS for 3 days using siRNA, and the kinetics of KU80 recruitment to DNA
each condition, nR 20. SE is shown for each time point.
(F) Quantification of NHEJmeasured as fold change in frequency of repair of EJ5-G
the indicated siRNA oligos or drugs. Bar graphs represent the mean of eight in
software). Panel below shows efficiency of knockdown using western blot.
(G) Quantification of HR measured as fold change in frequency of repair of DR-GF
the indicated siRNA oligos or drugs. Bar graphs represent the mean of eight in
software). Panels below show efficiency of knockdowns using western blot.
Cacrossmany experiments are summarized in Figure S4C. Finally,
we immunoprecipitated the TIMELESSmutants that cannot bind
PARP1 and found that these mutants were significantly impaired
in their binding to the PARP1 substrates (Figure 4B).
To further characterize the relationship between TIMELESS
and PARP1, we performed a number of experiments in which
TIMELESS levels were reduced using siRNA oligos. We first
investigated whether the absence of TIMELESS would affect
PARP1 ability to interact with its substrates. We found that
TIMELESS depletion led to a reduction of PARP1 binding to sub-
strates exclusively in cells in which DNA damage was induced by
treating cells for 15 min with neocarzinostatin (Figure 4C). This
effect cannot be secondary to changes in the cell-cycle profile,
since TIMELESS depletion does not affect the cell-cycle distri-
bution (Unsal-Kac¸maz et al., 2005; Yang et al., 2010).
We then asked whether TIMELESS has any role in the recruit-
ment of PARP1. When TIMELESS expression was silenced
(using two different oligos, individually), PARP1 recruitment to
laser-induced sites of DNA damage was reduced, but not
abolished (Figure 4D). TIMELESS depletion also robustly and
significantly impaired the recruitment of the DSB effector KU80
to DNA lesions (Figure 4E). Representative knockdown of
TIMELESS is shown in Figures 4F and 4G.
Finally, to understand the functional consequences of
TIMELESS silencing, we used I-SceI-based reporter assays
that generate a flow-cytometric readout to assess the contribu-
tion of TIMELESS to repair of DSBs. The DR-GFP reporter as-
says measures the efficiency of repair by HR, and the EJ5-GFP
reporter assay measures repair by non-homologous end-joining
(NHEJ). Cells depleted of TIMELESS exhibited highly significant
diminished repair in both systems (Figures 4F and 4G). Interest-
ingly, TIMELESS silencing did not synergize with DNA-PK inhibi-
tion in impairing NHEJ (Figure 4F), suggesting that they
cooperate in the same mechanism of repair. Together, these
data suggest that TIMELESS plays a role in regulating DNA
DSB repair.
DISCUSSION
Both TIMELESS and PARP1 have established roles in the
response to genotoxic stress: TIMELESS (together with its
known interactor, TIPIN) as a mediator of the response to DNA
replication stress, enabling the activation of the CHK1 signalingontrol non-targeting siRNA (siCTRL). 24 hr later cells were then transfectedwith
cted to IP with a-FLAG resin and immunoblotted as indicated. White asterisks
al results.
n of TIMELESS. U2OS cells stabling expressing PARP1-GFP were depleted of
NA damage sites were assessed by live-cell imaging of laser-induced lesions.
n of TIMELESS. U2OS cells stabling expressing KU80-GFP were depleted of
damage sites were assessed by live-cell imaging of laser-induced lesions. For
FP, resulting inGFP-positive cells after expression of I-SceI in cells treatedwith
dependent experiments ± SD. p < 0.0001 (unpaired t test, using GraphPad
P, resulting in GFP-positive cells after expression of I-SceI in cells treated with
dependent experiments ± SD. p < 0.0001 (unpaired t test, using GraphPad
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cascade, which in turn inhibits mitosis; and PARP1 as a key initi-
ator of the response to SSBs and DSBs, leading to activation of
the CHK2 signaling cascade, which in turn amplifies the DDR for
efficient DNA repair (Ciccia and Elledge, 2010). While these two
pathways have been shown to be capable of significant redun-
dancy, especially in downstream steps of their activation,
TIMELESS and PARP1, as very early mediators of very different
types of stress, have not previously been shown to interact or
contribute to the same types of DNA repair.
In this study, we show that TIMELESS forms a stable and,
apparently, near-stoichiometric complex with PARP1. In fact,
co-immunoprecipitates display similar intensity of bands with
both Ponceau S and silver staining dyes (Figures 1A, S1A, and
S4A) and a comparable number of PARP1 and TIMELESS pep-
tides by mass spectrometry (Figure S4B). These data, together
with the overlapping signal of TIMELESS and PARP1 foci de-
tected by super-resolution microscopy (Figures 1E and 1F), sug-
gest that the binding between TIMELESS and PARP1 may be
direct. Accordingly, the crystal structure of two proteins binding
to each other has been recently resolved at the atomic level (Xie
et al., 2015).
The complex that TIMELESS forms with TIPIN is distinct from
the TIMELESS-PARP1 complex, since TIPIN does not co-immu-
noprecipitate with PARP1 (as detected by either immunoblot or
mass spectrometry), and certain TIMELESS mutants, which
are unable to interact with PARP1, still bind TIPIN (Figures 4A–
4C, S4B, and S4C).
We found that seven single amino acids in TIMELESS are
involved in its binding with PARP1 (Figure 2). Interestingly,
Thr1089 and Ser1099, which are in the PARP1 binding domain
of TIMELESS, are also part of a TQ and SQ motif, respectively.
However, neither the Ala nor Asp mutant of these two residues
is sufficient to abrogate binding of TIMELESS to PARP1 (Fig-
ure 2), suggesting that their phosphorylation may not play a
role in regulating their interaction. Accordingly, ATM and ATR in-
hibitors have no effect on the TIMELESS-PARP1 complex (data
not shown). In contrast, mutation of Thr1078 to Asp completely
inhibits TIMELESS-PARP1 interaction, leading to the specula-
tion that phosphorylation of Thr1078 by a yet to be identified
kinase may be a prerequisite to dissociate the two proteins,
likely by inhibiting the contact between Gln1076, Phe1079, and
Arg1081 in TIMELESS with Ile879, Phe851, and Asp993 in
PARP1, respectively (Xie et al., 2015).
Using laser microirradiation coupled with live-cell imaging, we
have also established that TIMELESS is rapidly recruited to sites
of DNA damage and this recruitment is dependent on PARP1
binding and independent of PARP1’s enzymatic activity, which
in fact increases the speed, intensity, and residence of
TIMELESS recruitment (Figures 3B, 3C, and S3B). Interestingly,
TIMELESS behaves in a manner opposite to that of known
PARP1 substrates, which are unable to accumulate at the laser
damage site when PARylation is enzymatically inhibited (Bai,
2015; Thomas and Tulin, 2013).
Significantly, upon DNA damage, TIMELSSS silencing de-
creases the interaction of PARP1 with its substrates and impairs
PARP1 and KU80 recruitment to laser-induced sites of DNA
damage (Figures 4C–4E). However, recruitment of LIG3 and
XRCC1 is not significantly affected (not shown). These findings458 Cell Reports 13, 451–459, October 20, 2015 ª2015 The Authorssuggest that TIMELESS stabilizes complex formation of
PARP1 with its substrates at the level of DNA lesions, at least
in the earliest moments of the response to DNA damage and
for certain substrates. Accordingly, TIMELESS knockdown
also significantly affects DNA DSB repair (Figures 4F and 4G).
Rescue experiments with wild-type TIMELESS and various mu-
tants were attempted. Unfortunately, they were technically chal-
lenging because persistent TIMELESS knockdown induced cell
death, which was difficult to control using exogenous proteins.
Thus, the demonstration that TIMELESS is involved in DNA
repair by virtue of its interactionwith PARP1will require clustered
regularly interspaced short palindromic repeat (CRISPR) knockin
cell lines, which will enable manipulation of the system with
greater precision.
In sum, our work suggests that TIMELESS and PARP1 operate
in a complex to mediate DNA repair. Thus, TIMELESS plays a
role distinct from its established, TIPIN-dependent function in
the intra-S phase checkpoint. Significantly, PARP1 has many
functions, including cytoplasmic and nuclear (Daniels et al.,
2015), yet how PARP1 works in response to different stimuli
and recognizes different substrates remains unknown. Our find-
ings suggest that TIMELESS is a cofactor for the DDR functions
of PARP1, and impairment of this critical axis confers significant
deficits in the early response to DNA DSBs as well as to resolu-
tion of DSBs via canonical repair pathways.
EXPERIMENTAL PROCEDURES
Laser-Induced DNA Damage and Live-Cell Imaging
Cells were plated at a density of 75,000 per well on a four-well Lab-Tek II
chambered number 1.5 borosilicate coverglass and incubated overnight
before live-cell imaging. RNA knockdown experiments were performed 2 or
3 days prior to microscopy for TIMELESS and PARP1 knockdowns, respec-
tively. Cell culture medium was exchanged to DMEM lacking phenol red and
supplemented with sodium pyruvate and HEPES buffer on the day of data
collection. Imaging was performed using a DeltaVision Elite inverted micro-
scope system (Applied Precision), using a PlanApo 603 oil 1.42 numerical
aperture objective from Olympus. Excitation was achieved with a 7 Color
Combined Insight solid state illumination system and was equipped with a
polychroic beam splitter and filter sets to support the following wavelengths
pertinent to these studies: GFP (525/48) and mCherry (625/45). The system
is equipped with a CoolSNAP HQ2 camera and SoftWorx imaging software
version 5.0. DNA lesions were introduced using a 405-nm, 50-mW laser at
100% power for 0.5 or 1 s as indicated. Three pre-laser images were recorded
in all cases; the number and interval of post-laser images is indicated for each
experiment and varied by the protein studied in each experiment. Recruitment
intensity was analyzed using amacro written for ImageJ that calculated the ra-
tio of intensity of a circumscribed laser spot A to the adjacent area B such that
an RFU for each data collection point was calculated by the equation RFU =
(A  C)/(B  C), where C is the background intensity of an unpopulated area
of the image. In cases in which recruitment was not detectable, A was deter-
mined by use of laser coordinates recorded in the data log file.
Antibodies
The following antibodies were used: anti-TIMELESS (Bethyl Laboratories,
A300-961A and A300-960A, the latter used for IP), anti-PARP1 (Invitrogen,
436400), anti-PARP1 (Cell Signaling Technology, 9542 and 46D11, the latter
used for IF), anti-FLAG M2 (Sigma, F3165), anti-p-Chk1 (Cell Signaling,
2344), anti-p-Chk2 (Cell Signaling, 2661), anti-p-ATM (Cell Signaling, 4526),
anti-LIG3 (Bethyl, A301-637A), anti-HLTF (Bethyl, A300-229A), anti-KU70
(Santa Cruz Biotechnology, sc-9033), anti-KU80 (Neomarkers, MS-285-P1;
Cell Signaling, 2180), anti-XRCC1 (Cell Signaling, 2735), anti-DNA-PK (Santa
Cruz, sc-5282), anti-DNA-PK (Cell Signaling, 12311), anti-TIPIN (Bethyl,
A301-474A-1), anti-RPA1 (Santa Cruz, sc46504), anti-RPA2 (Millipore, 04-
1481), anti-SSRP1 (Abcam, ab26212), anti-SPT16 (Cell Signaling, 12191),
anti-SKP1 (Santa Cruz, sc-5281), and anti-phospho-H2AX (Millipore, 05-636).
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